Morningstar Investment Management LLC Acquires 24,595 Shares of Healthpeak Properties, Inc. $DOC

Morningstar Investment Management LLC boosted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 8.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 310,140 shares of the real estate investment trust’s stock after buying an additional 24,595 shares during the quarter. Morningstar Investment Management LLC’s holdings in Healthpeak Properties were worth $5,096,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Fiduciary Trust Co raised its holdings in Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock valued at $264,000 after buying an additional 644 shares in the last quarter. Patton Fund Management Inc. boosted its stake in shares of Healthpeak Properties by 5.2% during the 4th quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after acquiring an additional 648 shares in the last quarter. Quadrant Capital Group LLC increased its holdings in shares of Healthpeak Properties by 1.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after acquiring an additional 718 shares during the last quarter. Quantum Portfolio Management LLC increased its holdings in shares of Healthpeak Properties by 2.5% during the 1st quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust’s stock valued at $483,000 after acquiring an additional 728 shares during the last quarter. Finally, Intrua Financial LLC raised its stake in shares of Healthpeak Properties by 1.1% in the 1st quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust’s stock valued at $1,096,000 after acquiring an additional 744 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. BMO Capital Markets boosted their target price on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, June 15th. Wells Fargo & Company increased their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a report on Wednesday, July 15th. Morgan Stanley reissued an “equal weight” rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a research report on Thursday, June 11th. Raymond James Financial started coverage on shares of Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating for the company. Finally, Citigroup upped their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $20.62.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares in the company, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Trading Up 1.0%

Healthpeak Properties stock opened at $22.29 on Friday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The business’s 50-day simple moving average is $20.74 and its 200-day simple moving average is $18.45. The firm has a market capitalization of $15.37 billion, a PE ratio of 69.67, a PEG ratio of 3.43 and a beta of 1.02. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $22.77.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. During the same quarter in the previous year, the firm earned $0.46 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities research analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be given a $0.1017 dividend. This represents a c) annualized dividend and a yield of 5.5%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s payout ratio is currently 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.